PS Management GP, LLC, Director at Valeant Pharmaceuticals International, Inc. (VRX), sold 18,114,432 shares at $11.00 ($199.3M) on 2017-03-13, disclosed to the SEC on 2017-03-14.
Open-market sale of $199.3M VRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HHH | BUY | 2023-11-09 | $22.8M | — | Filing → |
| HHH | BUY | 2023-11-01 | $12.7M | — | Filing → |
| HHH | BUY | 2023-10-19 | $9.7M | — | Filing → |